BlackRock’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$616M Buy
14,259,479
+901,983
+7% +$38.9M 0.01% 915
2025
Q1
$462M Sell
13,357,496
-352,150
-3% -$12.2M 0.01% 1090
2024
Q4
$376M Buy
13,709,646
+830,136
+6% +$22.8M 0.01% 1262
2024
Q3
$328M Buy
12,879,510
+431,238
+3% +$11M 0.01% 1360
2024
Q2
$315M Buy
12,448,272
+1,981,337
+19% +$50.2M 0.01% 1310
2024
Q1
$324M Buy
10,466,935
+310,162
+3% +$9.59M 0.01% 1306
2023
Q4
$410M Buy
10,156,773
+906,830
+10% +$36.6M 0.01% 1144
2023
Q3
$244M Sell
9,249,943
-331,786
-3% -$8.75M 0.01% 1402
2023
Q2
$165M Buy
9,581,729
+463,948
+5% +$7.98M ﹤0.01% 1706
2023
Q1
$151M Sell
9,117,781
-650,410
-7% -$10.8M ﹤0.01% 1740
2022
Q4
$74.4M Buy
9,768,191
+502,323
+5% +$3.83M ﹤0.01% 2193
2022
Q3
$92.1M Sell
9,265,868
-92,713
-1% -$922K ﹤0.01% 2000
2022
Q2
$85M Buy
9,358,581
+214,374
+2% +$1.95M ﹤0.01% 2106
2022
Q1
$92.8M Sell
9,144,207
-131,383
-1% -$1.33M ﹤0.01% 2164
2021
Q4
$155M Sell
9,275,590
-865,721
-9% -$14.4M ﹤0.01% 1910
2021
Q3
$475M Buy
10,141,311
+640,990
+7% +$30M 0.01% 1013
2021
Q2
$579M Buy
9,500,321
+427,684
+5% +$26.1M 0.02% 895
2021
Q1
$559M Buy
9,072,637
+2,555,093
+39% +$157M 0.02% 907
2020
Q4
$463M Buy
6,517,544
+397,407
+6% +$28.3M 0.01% 948
2020
Q3
$230M Buy
6,120,137
+561,651
+10% +$21.1M 0.01% 1276
2020
Q2
$181M Buy
5,558,486
+335,888
+6% +$11M 0.01% 1428
2020
Q1
$151M Buy
5,222,598
+2,562,875
+96% +$74.3M 0.01% 1358
2019
Q4
$93.2M Buy
2,659,723
+1,184,951
+80% +$41.5M ﹤0.01% 1998
2019
Q3
$31.7M Buy
1,474,772
+1,421,272
+2,657% +$30.5M ﹤0.01% 2528
2019
Q2
$1.44M Buy
+53,500
New +$1.44M ﹤0.01% 3835